|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.52 CAD||0.01 (+1.96%)||0.39 - 0.88||1.0 thousand (Below Avg)|
Market data as of 12:00AM 10/23/14. Quotes are delayed by at least 15 min.
Antibe Therapeutics Completes Single Ascending Dose Portion of ATB-346 Phase I Program
Business Wire - Monday 10/06/2014 7:30 AM ET
Antibe Therapeutics Reports on Results of AGM Voting
Business Wire - Friday 10/03/2014 7:30 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.